Drug Holiday Effect in patients with melanoma resolved


Most melanoma patients with a mutation in the BRAF gene benefit from BRAF inhibitors. Over time, all tumors develop resistance against these drugs. Surprisingly, this acquired resistance can disappear after a medication pause. Prof. dr. René Bernards and his team of the Netherlands Cancer Institute resolved the mystery of this 'drug holiday effect'. Their findings are published today in the journal Nature.

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.